Sage Therapeutics Inc (SAGE)

5.495 -0.12 (-2.05%) USD  |  NASDAQ  |  Dec 23, 14:47
More

Sage Therapeutics Cash and Short Term Investments (Quarterly): 569.15M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for SAGE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Outset Medical Inc 175.63M
Biogen Inc 1.699B
Johnson & Johnson 20.30B
Lifecore Biomedical Inc 5.52M
Poseida Therapeutics Inc 230.85M